These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10083405)

  • 21. Peripheral blood microchimerism in female renal recipients from male donors.
    Hakemi M; Najafi I; Ganji MR; Khosravi F; Nikbin B
    Transplant Proc; 2001 Aug; 33(5):2852-3. PubMed ID: 11498186
    [No Abstract]   [Full Text] [Related]  

  • 22. Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantation.
    Dengler TJ; Szabo G; Amann K; Nottmeyer W; Vahl C; Hagl S; Zimmermann R
    Transplant Proc; 1998 May; 30(3):868-70. PubMed ID: 9595130
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of chimeric acid and non-chimeric tolerance using posttransplant total lymphoid irradiation: cytokine expression and chronic rejection.
    Hayamizu K; Lan F; Huie P; Sibley RK; Strober S
    Transplantation; 1999 Oct; 68(7):1036-44. PubMed ID: 10532547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
    Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
    Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of peripheral tolerance by posttransplant infusion of donor splenocytes.
    Tsui TY; Jäger MD; Deiwick A; Klempnauer J; Schlitt HJ
    Transplant Proc; 2001; 33(1-2):187-8. PubMed ID: 11266773
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
    Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
    Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of cell surface molecules in tolerance induction after intrathymic injection of donor splenocytes.
    Hirano T; Nakafusa Y; Nishinaka H; Takeda K; Kawano R; Nakano M; Arima T; Motoyama K; Kamei T; Tanaka M
    Transplant Proc; 1997; 29(1-2):1072. PubMed ID: 9123204
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of recipient T cell subset depletion on graft coronary arteriosclerosis induction in the rat retransplant model.
    Izutani H; Miyagawa S; Shirakura R; Mikata S; Tanemura M; Fukushima N; Nakata S; Matsuda H
    Transplant Proc; 1996 Jun; 28(3):1828-9. PubMed ID: 8658903
    [No Abstract]   [Full Text] [Related]  

  • 30. Origin and function of microchimeric cells. I. Irradiation sensitivity.
    Hara MH; Shibata K; Sekiya R; Matsuzaki Y; Onitsuka T; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Iwaya M; Suzuki S; Amemiya H; Kimura H
    Transplant Proc; 1996 Jun; 28(3):1246-7. PubMed ID: 8658643
    [No Abstract]   [Full Text] [Related]  

  • 31. Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine.
    Brunson ME; Tchervenkov JI; Alexander JW; Cofer BR
    Transplant Proc; 1991 Feb; 23(1 Pt 1):307-8. PubMed ID: 1990538
    [No Abstract]   [Full Text] [Related]  

  • 32. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism.
    Shirwan H; Wang HK; Barwari L; Makowka L; Cramer DV
    Transplantation; 1996 May; 61(9):1382-6. PubMed ID: 8629301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Passenger leukocytes from a heart allograft can induce lethal lymphoid aplasia.
    Ko S; Deiwick A; Dinkel A; Wonigeit K; Schlitt HJ
    Transplant Proc; 1999; 31(1-2):139-40. PubMed ID: 10083048
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow.
    Terakura M; Murase N; Demetris AJ; Ye Q; Thomson AW; Starzl TE
    Transplantation; 1998 Aug; 66(3):350-7. PubMed ID: 9721804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys.
    Kawai T; Cosimi AB; Wee SL; Houser S; Andrews D; Sogawa H; Phelan J; Boskovic S; Nadazdin O; Abrahamian G; Colvin RB; Sach DH; Madsen JC
    Transplantation; 2002 Jun; 73(11):1757-64. PubMed ID: 12084998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of PCR microchimerism induced by intrathymic inoculation of donor alloantigens in rats.
    Furukawa M; Fukuda Y; Tashiro H; Ohdan H; Hoshino S; Shintaku S; Itou H; Kiyohiko D
    Cell Transplant; 1996; 5(5 Suppl 1):S75-7. PubMed ID: 8889237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term survival of cardiac xenografts in fully xenogeneic (mouse --> rat) bone marrow chimeras.
    Mohiuddin MM; Qin Y; Qian X; Meng Y; DiSesa VJ
    Ann Thorac Surg; 2001 Sep; 72(3):740-5; discussion 745-6. PubMed ID: 11565651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recipient-donor microchimerism is not a prerequisite for the maintenance of allograft tolerance.
    Shirwan H; Wang C; Barwari L; Cramer DV
    Transplant Proc; 1997; 29(1-2):1182-3. PubMed ID: 9123263
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitis in rat cardiac allografts.
    Paul LC; Davidoff A; Paul DW; Benediktsson H; Issekutz TB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):813-4. PubMed ID: 8438494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.